BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009;23:147-57. [PMID: 19414142 DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications. Cancer Discov 2023;13:538-51. [PMID: 36757194 DOI: 10.1158/2159-8290.CD-22-1038] [Reference Citation Analysis]
2 Çağlar R. The relationship of different preoperative inflammatory markers with the prognosis of gastric carcinoma. Asian J Surg 2023;46:360-5. [PMID: 35589478 DOI: 10.1016/j.asjsur.2022.04.075] [Reference Citation Analysis]
3 Bhardwaj P, Bhandari G, Kumar Y, Gupta S. An Investigational Approach for the Prediction of Gastric Cancer Using Artificial Intelligence Techniques: A Systematic Review. Arch Computat Methods Eng. [DOI: 10.1007/s11831-022-09737-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Klein S, Duda DG. Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas. Cancers (Basel) 2021;13:4919. [PMID: 34638408 DOI: 10.3390/cancers13194919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Devezas V, Baptista M, Gullo I, Rocha J, Sousa F, Xiaogang W, Preto J, Costa S, Castedo S, Garrido L, Oliveira C, Barbosa E, Carneiro F, Barbosa J. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. Eur Surg 2020;52:171-178. [DOI: 10.1007/s10353-020-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Afrouz S, Ghatee MA, Roozbehi A, Sangtarash MH. Detection of R282w P53 Gene Mutation on Exon 8 in Gastric Cancer Patients in Southwest Iran. Gene Cell Tissue 2020;7. [DOI: 10.5812/gct.103317] [Reference Citation Analysis]
7 Choe AR, Shim K, Kim TO, Kim SY, Lim J, Tae CH, Moon CM, Kim S, Jung H, Jung S. Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of a Gastric Neoplasm. Korean J Helicobacter Up Gastrointest Res 2019;19:184-192. [DOI: 10.7704/kjhugr.2019.19.3.184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, Dixon K, Figueiredo J, Ghosh R, Huntsman D, Kaurah P, Kesserwan C, Landrith T, Li S, Mensenkamp AR, Oliveira C, Pardo C, Pesaran T, Richardson M, Slavin TP, Spurdle AB, Trapp M, Witkowski L, Yi CS, Zhang L, Plon SE, Schrader KA, Karam R. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat 2018;39:1553-68. [PMID: 30311375 DOI: 10.1002/humu.23650] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 24.0] [Reference Citation Analysis]
9 Blocka J, Durie BGM, Huhn S, Mueller-Tidow C, Försti A, Hemminki K, Goldschmidt H. Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an Example. Clin Lymphoma Myeloma Leuk 2019;19:635-644.e2. [PMID: 31377209 DOI: 10.1016/j.clml.2019.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
10 Abrams B, Wavreille VA, Husbands BD, Matz BM, Massari F, Liptak JM, Cray MT, de Mello Souza CH, Wustefeld-Janssens BG, Oblak ML, Su L, Selmic LE. Perioperative complications and outcome after surgery for treatment of gastric carcinoma in dogs: A Veterinary Society of Surgical Oncology retrospective study of 40 cases (2004-2018). Vet Surg 2019;48:923-32. [PMID: 31140634 DOI: 10.1111/vsu.13239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874-883. [PMID: 30507471 DOI: 10.1016/s2468-1253(18)30237-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
12 Morais S, Antunes L, Bento MJ, Lunet N. The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer. Eur J Gastroenterol Hepatol 2019;31:471-7. [PMID: 30601339 DOI: 10.1097/MEG.0000000000001348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yusupova LF, Nurgalieva AK, Gilyazova IR, Prokofyeva DS, Munasypov FR, Khusnutdinov SM, Rakhimov RR, Abdeev RR, Sakaeva DD, Khusnutdinova EK. The Role of Allelic Variants of Several Genes of Cytokines in the Development of Gastric Cancer. Russ J Genet 2019;55:378-387. [DOI: 10.1134/s1022795419030165] [Reference Citation Analysis]
14 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sokolenko AP, Imyanitov EN. Molecular Diagnostics in Clinical Oncology. Front Mol Biosci 2018;5:76. [PMID: 30211169 DOI: 10.3389/fmolb.2018.00076] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 13.2] [Reference Citation Analysis]
16 van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin. 2017;10:931-945. [PMID: 29103540 DOI: 10.1016/j.path.2017.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
17 Huang DS, Tao HQ, He XJ, Long M, Yu S, Xia YJ, Wei Z, Xiong Z, Jones S, He Y, Yan H, Wang X. Prevalence of deleterious ATM germline mutations in gastric cancer patients. Oncotarget 2015;6:40953-8. [PMID: 26506520 DOI: 10.18632/oncotarget.5944] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
18 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
19 Hereditary Diffuse Gastric Cancer. Diagnostic Pathology: Gastrointestinal 2016. [DOI: 10.1016/b978-0-323-37673-0.50057-4] [Reference Citation Analysis]
20 Schmelzle M, Jonas S, Strumberg D, Kaufmann A, Aretz S, Pietsch U, Kaisers UX, Monz K, Hartmann K, Hübner J, Lordick F, Raida M, Winter A, Burkholder I, Edler L. Grundlagen der gastrointestinalen Tumorerkrankungen. Viszeralmedizin 2015. [DOI: 10.1007/978-3-642-14301-4_28] [Reference Citation Analysis]
21 Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V. E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014;33:1081-94. [PMID: 25332147 DOI: 10.1007/s10555-014-9528-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
22 Sanches JM, Figueiredo J, Fonseca M, Durães C, Melo S, Esménio S, Seruca R. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet 2015;23:1072-9. [PMID: 25388006 DOI: 10.1038/ejhg.2014.240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
23 Gaston D, Hansford S, Oliveira C, Nightingale M, Pinheiro H, Macgillivray C, Kaurah P, Rideout AL, Steele P, Soares G, Huang WY, Whitehouse S, Blowers S, LeBlanc MA, Jiang H, Greer W, Samuels ME, Orr A, Fernandez CV, Majewski J, Ludman M, Dyack S, Penney LS, McMaster CR, Huntsman D, Bedard K. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014;10:e1004669. [PMID: 25340522 DOI: 10.1371/journal.pgen.1004669] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
24 Grodecká L, Kramárek M, Lockerová P, Kováčová T, Ravčuková B, Richterová R, Kyselová K, Augste E, Freiberger T. No major effect of the CDH1 c.2440-6C>G mutation on splicing detected in last exon-specific splicing minigene assay: No Major Effect of CDH1 C.2440-6C>G On Splicing. Genes Chromosomes Cancer 2014;53:798-801. [DOI: 10.1002/gcc.22186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Durães C, Almeida GM, Seruca R, Oliveira C, Carneiro F. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch 2014;464:367-78. [DOI: 10.1007/s00428-013-1533-y] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 12.3] [Reference Citation Analysis]
26 Bordeira-Carriço R, Ferreira D, Mateus DD, Pinheiro H, Pêgo AP, Santos MA, Oliveira C. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 2014;22:1085-92. [PMID: 24424122 DOI: 10.1038/ejhg.2013.292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
27 Pinho SS, Carvalho S, Marcos-pinto R, Magalhães A, Oliveira C, Gu J, Dinis-ribeiro M, Carneiro F, Seruca R, Reis CA. Gastric cancer: adding glycosylation to the equation. Trends in Molecular Medicine 2013;19:664-76. [DOI: 10.1016/j.molmed.2013.07.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
28 Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 2013;8:e77035. [PMID: 24204729 DOI: 10.1371/journal.pone.0077035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
29 Zuk K, Peczek L, Stec-Michalska K, Medrek M, Nawrot B. SATB1 expression in gastric mucosa in relation to Helicobacter pylori infection and family history of gastric cancer. Adv Med Sci 2012;57:237-43. [PMID: 23188721 DOI: 10.2478/v10039-012-0049-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Carlos GC. Actualización del diagnóstico y tratamiento del cáncer gástrico. Revista Médica Clínica Las Condes 2013;24:627-636. [DOI: 10.1016/s0716-8640(13)70201-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Chang VY, Federman N, Martinez-Agosto J, Tatishchev SF, Nelson SF. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer 2013;60:570-4. [PMID: 23015295 DOI: 10.1002/pbc.24316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
32 Fang WL, Chang SC, Lan YT, Huang KH, Lo SS, Li AF, Chi CW, Wu CW, Chiou SH. Molecular and survival differences between familial and sporadic gastric cancers. Biomed Res Int 2013;2013:396272. [PMID: 23555086 DOI: 10.1155/2013/396272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
33 Oliveira C, Seruca R, Hoogerbrugge N, Ligtenberg M, Carneiro F. Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC). Eur J Hum Genet. 2013;21. [PMID: 23443028 DOI: 10.1038/ejhg.2012.247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
34 Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol 2013;229:705-18. [PMID: 23180380 DOI: 10.1002/path.4143] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
35 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
36 Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS, Lauwers GY. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: Biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol. 2012;36:1709-1717. [PMID: 23073328 DOI: 10.1097/pas.0b013e31826ca204] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
37 Hansford S, Huntsman D. Beyond CDH1 Mutations: Causes of Hereditary Diffuse Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_9] [Reference Citation Analysis]
38 Leite M, Corso G, Sousa S, Carvalho J, Roviello F, Oliveira C, Figueiredo C, Seruca R. Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_10] [Reference Citation Analysis]
39 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal malignancies. World J Gastroenterol 2012; 18(33): 4507-4516 [PMID: 22969223 DOI: 10.3748/wjg.v18.i33.4507] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
41 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer 2012;15 Suppl 1:S153-63. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
42 Dixon M, Seevaratnam R, Wirtzfeld D, Mcleod R, Helyer L, Law C, Swallow C, Paszat L, Bocicariu A, Cardoso R, Mahar A, Bekaii-saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, Van de Velde CJH, Wong S, Coburn N. A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer. Ann Surg Oncol 2013;20:533-41. [DOI: 10.1245/s10434-012-2584-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
43 Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B. Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol 2012;25:1055-68. [PMID: 22522846 DOI: 10.1038/modpathol.2012.62] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
44 Figueiredo J, Söderberg O, Simões-Correia J, Grannas K, Suriano G, Seruca R. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 2013;21:301-9. [PMID: 22850631 DOI: 10.1038/ejhg.2012.159] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
45 Zuk K, Peczek L, Stec-Michalska K, Medrek M, Nawrot B. Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients. Oncol Lett 2012;3:219-23. [PMID: 22740884 DOI: 10.3892/ol.2011.456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
46 Corso G, Marrelli D, Roviello F. Familial gastric cancer: update for practice management. Fam Cancer 2011;10:391-6. [PMID: 21184285 DOI: 10.1007/s10689-010-9410-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
47 Zhou LP, Luan H, Dong XH, Jin GJ, Man DL, Shang H. Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis. Exp Ther Med 2011;2:931-6. [PMID: 22977600 DOI: 10.3892/etm.2011.278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Chen S, Lin X, Zhu J, Tang Y, Lin J. Association of a MYCL1 Single Nucleotide Polymorphism, rs3134613, with Susceptibility to Diffuse-Type Gastric Cancer and with Differentiation of Gastric Cancer in a Southeast Chinese Population. DNA and Cell Biology 2010;29:739-43. [DOI: 10.1089/dna.2010.1096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
49 Melton SD, Genta RM, Souza RF. Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms. Nat Rev Gastroenterol Hepatol 2010;7:620-8. [PMID: 20924366 DOI: 10.1038/nrgastro.2010.153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
50 Wolf E, Geigl J, Svrcek M, Vieth M, Langner C. Hereditäres Magenkarzinom. Pathologe 2010;31:423-9. [DOI: 10.1007/s00292-010-1353-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010;18:33S-36S. [PMID: 20484258 DOI: 10.1177/1066896910366463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
52 Vieth M, Görgens D, Langner C. [Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis]. Pathologe 2010;31:171-6. [PMID: 20336298 DOI: 10.1007/s00292-009-1266-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
53 Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Soares JM, Castedo S, Carneiro F, Roviello F. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer. 2011;128:1606-1613. [PMID: 20533283 DOI: 10.1002/ijc.25495] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]